What would you like to look for?
Site search
Search filters

Sale of T3 Pharmaceuticals AG to Boehringer Ingelheim

23 November 2023

T3 Pharmaceuticals AG, a biotechnology company with its headquarter in Allschwil, Switzerland has been acquired by Boehringer Ingelheim, a leading family-owned, research-driven biopharmaceutical company based in Ingelheim, Germany...

Immunotherapy startup Anaveon supported by UZH Life Sciences Fund

26 June 2018

With the help of investments of the UZH Life Sciences Fund and the BaseLaunch funding programme, Onur Boyman and Andreas Katopodis founded the spin-off Anaveon AG. Onur Boyman, Director of the Department of Immunology at the...